Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

155.90 +1.40 (+0.90%)

Streaming Delayed Price Updated: 1:41 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Small Cap Biotech Stocks: Is it time to start trading? ↗

January 31, 2022

It’s time to trade beaten-up small cap biotech stocks.

Via Talk Markets

3 Pharma Stocks Yielding Over 3% ↗

January 18, 2022

The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.

Via Talk Markets

9 Monster Stock Market Predictions – The Week Of Jan. 17 ↗

January 17, 2022

The chart for the SPX is looking more and more like a diamond pattern.

Via Talk Markets

3 Biotech Stocks to Buy That Are Under Severe Pressure ↗

January 13, 2022

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

Via InvestorPlace

Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗

January 10, 2022

Pfizer and Bayer inked deals with several companies in gene-editing.

Via Investor's Business Daily

Top 10 Investment Themes For 2022 ↗

December 25, 2021

What are the investment trends going to look like for 2022?

Via Talk Markets

ETF Battles: Which Biotech Stock ETF Is The Better Choice? - It's IBB Vs. XBI ↗

December 23, 2021

A biotech clash between the iShares Biotechnology ETF and the SPDR S&P Biotech ETF.

Via Talk Markets

Whitney Tilson Names Cannabis ETF 'Favorite Pick For 2022' But Clock Is Ticking To Change US Regulations ↗

January 03, 2022

It was another brutal year for cannabis stock investors in 2021 as the U.S. made very little regulatory progress on cannabis reform measures. Fortu...

Via Benzinga

Fear & Greed In The Biotech Sector ↗

January 02, 2022

With rates rising, widespread tax-loss selling, and fund manager’s either closing the books for 2021 or just closing down altogether, the market has entered a major risk off phase and biotech stocks...

Via Talk Markets

Healthcare Stocks Are Winners And Provide Diversification To Your Portfolio ↗

December 30, 2021

As we have written their year many times speculative small cap biotechs have not done well in 2021 since they peaked in February.

Via Talk Markets

The Bear Market Is Already Here – But Not For Dividend Investors ↗

December 22, 2021

While the broad stock market indices remain at near-record levels, there are sectors of the market that have dropped into correction or even bear market territory over recent months.

Via Talk Markets

Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot ↗

December 22, 2021

The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.

Via Talk Markets

10 Bargain Stocks to Buy After Falling 30% in 2021 ↗

December 20, 2021

If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill.

Via InvestorPlace

Biotech Playbook 2021: No Help From Small Caps In Q4 ↗

December 14, 2021

Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...

Via Talk Markets

8 Monster Stock Market Predictions – The Week Of December 13, 2021 Edition ↗

December 12, 2021

Via Talk Markets

5 Top-Ranked ETFs to Buy At Bargain Prices ↗

December 08, 2021

The beaten-down prices have charged up investors to snap up ETFs on the cheap. Investors could definitely look to these products for outsized gains over the longer term.

Via Talk Markets

How Did Healthcare Stocks Perform Over This Volatile Month? ↗

December 06, 2021

It’s been a rough month for small-cap biotech stocks amidst a general correction in the market which brought general indices down about 10%.

Via Talk Markets

Tuesday Talk: O(micron) - Pow(ell)! ↗

November 30, 2021

As Wall St. investors await the market open Tuesday, futures dive on Omicron concerns as well as anticipation surrounding Yellen and Powell's Senate testimony this morning.

Via Talk Markets

Stocks Rise On November 29 On Predictable Volatility Crush ↗

November 29, 2021

Stocks jumped on November 29 as volatility came down sharply.

Via Talk Markets

COVID Is Back Disrupting Markets And Causing More Sector Uncertainty ↗

November 29, 2021

Just when you were having an enjoyable four day weekend cruising along the interminable bull market COVID is back disrupting trends. Healthcare stocks held up reasonably well .Will there be new respect...

Via Talk Markets

Biotech Stocks are Due for a Rally ↗

November 22, 2021

There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.

Via Talk Markets

Looking for Growth in Small and Mid Cap Life Science Stocks ↗

November 15, 2021

2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.

Via Talk Markets

How Are Biotech ETFs Reacting To These Q3 Earnings Releases? ↗

November 06, 2021

There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see...

Via Talk Markets

Wednesdays With Wedbush On PreMarket Prep Plus ↗

November 03, 2021

On the PreMarket Prep Plus "Wednesday’s With Wedbush" segment, Sahak Manuelian, managing director and head of equi...

Via Benzinga

15 Charts All Traders Should Look At Every Morning ↗

September 30, 2021

One of the hardest things to do as a day trader is gathering all the necessary information to execute profitable trades. Below are the to...

Via Benzinga

Look For The Q4 Biotech Bounce In Mid-Small Caps ↗

September 17, 2021

Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best...

Via Talk Markets

Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market ↗

September 09, 2021

Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.

Via Talk Markets

Healthcare Stocks Hit New Highs but Small Caps Lag ↗

August 23, 2021

Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field.

Via Talk Markets

ETF Reflections: US Stocks ↗

August 21, 2021

I'm a bear. So the longer they prop this dreck up, the greater the fall. Suits me!

Via Talk Markets

Biotech ETFs To Benefit From Latest Booster Update ↗

August 21, 2021

Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from...

Via Talk Markets

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.